WEE1 and cancer: For this purpose, we selected the three proteins encoded by ALK, EGLN3, and NUAK1 as drug targets, based upon a literature search and the gene annotations that indicated that these genes were expressed in cancer and had potentially functional binding pockets (e.g., protein kinase) for ligands.